Latest cholesterol drug comes with a $14,600-a-year price tag

Five things to know about Praluent, the cholesterol drug that was approved by the FDA this summer.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.